SILTRAX EPI NO. 8
Natural health product licensed in Canada
- Licence holder
- Pascal International Corporation
- NPN or DIN-HM
- 02097737
- Status
- Active licence
- Licence date
- 10 October 2007
- Revision date
- Not provided
- Form
- Ficelle
- Route of administration
- Buccale, Dentaire
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Cotton Cord Twisted # 8, Phosphate de sodium, monobasique, Sodium Dithionite, Chlorure de sodium, Sodium Bisulfite, Eau purifiée, Éthanol, Chlorure de zinc, alcool benzylique, Acide phosphorique, Hydroxyde d'ammonium, Sodium Thiosulphate, anhydrous
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 cord | Not specified |
| Enfants | Not specified | 1 cord | Not specified |
Uses authorised in Canada
Use whenever gingival retraction is adviseable in dental practice; as preceding impression taking wiath any elastic impression material; or prior to placement of caps, crowns, bridges, etc. Sil-Trax EPI is braided cotton cord saturated with a solution of racemic epinephrine hydrochloride and dried by a technique which retains the activity of the medication. Normal tissue moisture reactivages the medication, which promptly retracts gingival tissue in a manner that causes no tissue damage, yet fully exposes the gingival margin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Retraction with an epinephrine cord should be limited to the equivalent of one normal quadrant of the mouth per appointment.
Source
Official Health Canada record, licence 02097737
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.